Controlled Release of Antigen and Toll-like Receptor Ligands From PLGA Nanoparticles Enhances Immunogenicity

Abstract

PLGA-encapsulated antigen and adjuvant showed an enhanced T-cell response when compared with soluble vaccine components by increasing antigenicity and adjuvanticity. Although the kinetic profile followed the same pattern, encapsulation increased strength and duration of the response.